Development Of Transdermal Nanofilm Containing Fluticasone Propionate: In-Vitro, In-Vivo Correlation

Read full text Summarise with VIRAT
Authors: Muhammad Irfan Siddique
Cited by: 0
References: 38

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Psoriasis is one of the chronic inflammatory skin conditions, affecting about 2-3% of the world population. Steroidal treatment are only best choice of treatments, but it is often associated with side effects due to higher lipophilicity. OBJECTIVES: In this work, a nanoparticle-loaded transdermal film was developed to maintain nanoparticle integrity in the skin. METHODS: Fluticasone propionate loaded chitosan nanoparticles (NPs) were developed, and their particle size, zeta potential, drug loading, entrapment efficiency and scanning electron microscope (SEM) images were determined. The NPs-loaded film was further characterized for appearance, thickness and Fourier Transform Infrared (FTIR) spectra, and an in vitro and in vivo permeation study was conducted. RESULTS: The particle size of FSNPs was found to be 250nm with +32.4 ±1.5 mV zeta potential, great entrapment efficiency and spherical in shape. In vivo dermato-kinetic studies showed long-term, confined drug release from the NP-formulated film in the epidermal layers, compared with the film containing free drug. CONCLUSION: The study demonstrated that the FSNPs-loaded film showed higher skin permeation, which is effective for managing psoriasis and warrants further evaluation.

Fields of Study & Subjects

Advancements in Transdermal Drug Delivery Advanced Drug Delivery Systems Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Pakistan Journal of Pharmaceutical Sciences
Volume
39
Issue
5
Pages
1529–1537
Publication date
19 March 2026
Language
EN